Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
In the latest session, Rocket Lab Corp (NASDAQ: RKLB) closed at $53.96 down -2.76% from its previous closing price of $55.49. In other words, the price has decreased by -$2.76 from its previous closing price. On the day, 23.66 million shares were traded. RKLB stock price reached its highest trading level at $56.91 during the session, while it also had its lowest trading level at $53.085.
Ratios:
For a deeper understanding of Rocket Lab Corp’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.83 and its Current Ratio is at 3.18. In the meantime, Its Debt-to-Equity ratio is 0.40 whereas as Long-Term Debt/Eq ratio is at 0.39.
Upgrades & Downgrades
In the most recent recommendation for this company, Needham on November 12, 2025, Reiterated its Buy rating but revised its target price to $63 from $55 previously.
On October 16, 2025, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $83.
On July 28, 2025, Craig Hallum started tracking the stock assigning a Hold rating and target price of $51.Craig Hallum initiated its Hold rating on July 28, 2025, with a $51 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Dec 17 ’25 when MERLINE A SAINTIL bought 5,000 shares for $55.49 per share.
Beck Peter sold 1,560,254 shares of RKLB for $89,675,375 on Dec 15 ’25. The CEO now owns 939,746 shares after completing the transaction at $57.47 per share. On Dec 16 ’25, another insider, Beck Peter, who serves as the CEO of the company, sold 939,746 shares for $54.73 each. As a result, the insider received 51,430,121 and left with 0 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RKLB now has a Market Capitalization of 28823074816 and an Enterprise Value of 28362958848. For the stock, the TTM Price-to-Sale (P/S) ratio is 51.98 while its Price-to-Book (P/B) ratio in mrq is 20.90. Its current Enterprise Value per Revenue stands at 51.147 whereas that against EBITDA is -147.543.
Stock Price History:
The Beta on a monthly basis for RKLB is 2.18, which has changed by 1.3897502 over the last 52 weeks, in comparison to a change of 0.15905356 over the same period for the S&P500. Over the past 52 weeks, RKLB has reached a high of $73.97, while it has fallen to a 52-week low of $14.71. The 50-Day Moving Average of the stock is -1.85%, while the 200-Day Moving Average is calculated to be 38.33%.
Shares Statistics:
For the past three months, RKLB has traded an average of 22.14M shares per day and 25580320 over the past ten days. A total of 496.22M shares are outstanding, with a floating share count of 483.31M. Insiders hold about 9.52% of the company’s shares, while institutions hold 50.09% stake in the company. Shares short for RKLB as of 1764288000 were 45204231 with a Short Ratio of 2.04, compared to 1761868800 on 50935958. Therefore, it implies a Short% of Shares Outstanding of 45204231 and a Short% of Float of 9.56.
Earnings Estimates
. The current assessment of Rocket Lab Corp (RKLB) involves the perspectives of 10.0 analysts closely monitoring its market dynamics.The consensus estimate for the next quarter is -$0.09, with high estimates of -$0.05 and low estimates of -$0.14.
Analysts are recommending an EPS of between -$0.36 and -$0.39 for the fiscal current year, implying an average EPS of -$0.38. EPS for the following year is -$0.24, with 11.0 analysts recommending between -$0.12 and -$0.43.
Revenue Estimates
A total of 12 analysts believe the company’s revenue will be $177.49M this quarter.It ranges from a high estimate of $185.57M to a low estimate of $174.6M. As of. The current estimate, Rocket Lab Corp’s year-ago sales were $132.39MFor the next quarter, 12 analysts are estimating revenue of $179.82M. There is a high estimate of $194.8M for the next quarter, whereas the lowest estimate is $157.7M.
A total of 14 analysts have provided revenue estimates for RKLB’s current fiscal year. The highest revenue estimate was $607.72M, while the lowest revenue estimate was $596.31M, resulting in an average revenue estimate of $599.4M. In the same quarter a year ago, actual revenue was $436.21MBased on 14 analysts’ estimates, the company’s revenue will be $879.49M in the next fiscal year. The high estimate is $1.06B and the low estimate is $734.4M.
